Bisphosphonates and risk of atrial fibrillation a meta-analysis.docVIP

  • 6
  • 0
  • 约3.48万字
  • 约 8页
  • 2017-05-16 发布于上海
  • 举报

Bisphosphonates and risk of atrial fibrillation a meta-analysis.doc

Bisphosphonates and risk of atrial fibrillation a meta-analysis

Kim et al. Arthritis Research Therapy 2010, 12:R30 /content/12/1/R30 RESEARCH ARTICLE Open Access Bisphosphonates and risk of atrial fibrillation: a Research article meta-analysis Seo Young Kim*1,2, Min Jung Kim3, Suzanne M Cadarette4 and Daniel H Solomon1,2 Abstract Introduction: Bisphosphonates are the most commonly used drugs for the prevention and treatment of osteoporosis. Although a recent FDA review of the results of clinical trials reported no clear link between bisphosphonates and serious or non-serious atrial fibrillation (AF), some epidemiologic studies have suggested an as

文档评论(0)

1亿VIP精品文档

相关文档